收藏切换
Comparison of Efficacy and Safety of Different Preparations of Intravenous Human Immunoglobulin for Kawasaki Disease Treatment in Children
收藏切换
PDF
Huawei ZHAO1, 2, Yuefang SHEN1, Wuxiao ZHOU3, Yinghua NI1, Yanhong LI1, Yangyang SUN1, Jing MIAO1, 2, *
Chinese Pharmaceutical Journal | 2024, 59(16) : 1545 - 1550
Less
收藏切换
Chinese Pharmaceutical Journal | 2024, 59(16): 1545-1550
Comparison of Efficacy and Safety of Different Preparations of Intravenous Human Immunoglobulin for Kawasaki Disease Treatment in Children
Full
Huawei ZHAO1, 2, Yuefang SHEN1, Wuxiao ZHOU3, Yinghua NI1, Yanhong LI1, Yangyang SUN1, Jing MIAO1, 2, *
Affiliations
  • 1 National Clinical Research Center for Child Health, Department of Pharmacy, Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310052, China
  • 2 Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou 310058, China
  • 3 Department of Pharmacy, Wuyi Maternal and Child Care Hospital, Jinhua 321200, China
Published: 2024-08-22 doi: 10.11669/cpj.2024.16.013
Outline
收藏切换

OBJECTIVE To investigate the efficacy and safety of different preparations of intravenous immunoglobulin (IVIG) for Kawasaki disease treatment in children. METHODS A retrospective analysis of medical records of pediatric Kawasaki disease patients at our institution in recent three years was conducted. Patients were divided into preparation A group and preparation B group based on the type of IVIG preparations used. Both groups received IVIG (2 g·kg-1) in conjunction with aspirin therapy following Kawasaki disease diagnosis. Changes in body temperature, white blood cell count, platelet count, C-reactive protein levels, IVIG cost, length of hospital stay, and adverse events were compared. RESULTS According to the drug labeling, there are certain differences between preparation A and preparation B. Preparation B exhibited a significantly shorter duration of fever resolution compared with preparation A (P<0.005), and at the first temperature test after infusion, the body temperature of preparation B group was significantly lower than that of preparation A group (P<0.05). Furthermore, preparation B demonstrated a more significant reduction in white blood cell count following treatment (P=0.010). In terms of hospital stay duration and IVIG monotherapy costs, preparation B had significantly shorter hospital stay (P<0.05) and lower per-unit IVIG expense (P<0.001). No significant differences were observed between the two groups in terms of adverse events, including rashes, infusion interruptions due to high fever, liver injury, and coronary dilation. CONCLUSION There is significant difference in efficacy between different preparations of intravenous immunoglobulin in the treatment of Kawasaki disease in children, but the safety is similar.

intravenous immunoglobulin  /  Kawasaki disease  /  preparation  /  fever resolution duration  /  adverse event
Huawei ZHAO, Yuefang SHEN, Wuxiao ZHOU, Yinghua NI, Yanhong LI, Yangyang SUN, Jing MIAO. Comparison of Efficacy and Safety of Different Preparations of Intravenous Human Immunoglobulin for Kawasaki Disease Treatment in Children[J]. Chinese Pharmaceutical Journal, 2024 , 59 (16) : 1545 -1550 . DOI: 10.11669/cpj.2024.16.013
Year 2024 volume 59 Issue 16
PDF
184
77
Cite this Article
BibTeX
Article Info
doi: 10.11669/cpj.2024.16.013
  • Receive Date:2023-11-16
  • Online Date:2025-10-29
  • Published:2024-08-22
Article Data
Affiliations
History
  • Received:2023-11-16
Funding
Affiliations
    1 National Clinical Research Center for Child Health, Department of Pharmacy, Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310052, China
    2 Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou 310058, China
    3 Department of Pharmacy, Wuyi Maternal and Child Care Hospital, Jinhua 321200, China
References
Share
https://castjournals.cast.org.cn/joweb/zgyxzz/EN/10.11669/cpj.2024.16.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT